Cite
HARVARD Citation
Mulder, J. et al. (2020). Breakthrough therapy-designated oncology drugs: are they rightfully criticized?. Drug discovery today. 25 (9), pp. 1580-1584. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mulder, J. et al. (2020). Breakthrough therapy-designated oncology drugs: are they rightfully criticized?. Drug discovery today. 25 (9), pp. 1580-1584. [Online].